Apyx Medical Affirms FY2026 Sales Guidance of $59.000M-$60.000M vs $59.554M Est

Benzinga Newsdesk www.benzinga.com Negative 74.2%

Neg 74.2% Neu 0% Pos 0%

Apyx Medical (NASDAQ:APYX) affirms FY2026 sales outlook from $59.000 million-$60.000 million to $59.000 million-$60.000 million vs $59.554 million estimate.